These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies. Hakalahti L, Vihko P, Henttu P, Autio-Harmainen H, Soini Y, Vihko R. Int J Cancer; 1993 Oct 21; 55(4):590-7. PubMed ID: 7691762 [Abstract] [Full Text] [Related]
4. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CY, Klee GG, Tindall DJ, Bostwick DG. Urology; 1997 Jun 21; 49(6):857-62. PubMed ID: 9187691 [Abstract] [Full Text] [Related]
5. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer. Grob BM, Schellhammer PF, Brassil DN, Wright GL. Urology; 1994 Oct 21; 44(4):525-9. PubMed ID: 7524238 [Abstract] [Full Text] [Related]
6. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. N Engl J Med; 1987 Oct 08; 317(15):909-16. PubMed ID: 2442609 [Abstract] [Full Text] [Related]
10. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study. Ersev A, Ersev D, Turkeri L, Ilker Y, Simsek F, Kullu S, Akdas A. Prog Clin Biol Res; 1990 Dec 08; 357():129-34. PubMed ID: 1699237 [Abstract] [Full Text] [Related]
11. [Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue]. Fujino A, Mukai N, Kawakami T, Yokoyama E, Mashimo S, Endo T, Ishibashi A, Koshiba K, Aoki Y, Itoh H. Nihon Hinyokika Gakkai Zasshi; 1991 Apr 08; 82(4):541-50. PubMed ID: 1711133 [Abstract] [Full Text] [Related]
16. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease. Buamah PK, Johnson P, Skillen AW. Br J Urol; 1988 Dec 08; 62(6):581-3. PubMed ID: 2464396 [Abstract] [Full Text] [Related]
19. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma]. Haukaas S, Skaarland E, Halvorsen OJ, Stensland E, Farstad M. Tidsskr Nor Laegeforen; 1990 Sep 30; 110(23):2990-3. PubMed ID: 1700496 [Abstract] [Full Text] [Related]
20. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material. Shah NT, Tuttle SE, Strobel SL, Gandhi L. J Surg Oncol; 1985 Aug 30; 29(4):265-8. PubMed ID: 2417056 [Abstract] [Full Text] [Related] Page: [Next] [New Search]